(Q44754581)

English

A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.

scientific article published in February 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

L H Visser

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R Beekman

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

C C Tijssen

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

B M J Uitdehaag

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M L Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

K L L Movig

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A W Lenderink

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

89-91

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

The natural history of multiple sclerosis: implications for trial design

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

Evaluation of experiments with adaptive interim analyses.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS978SR

21 January 2018

Identifiers

10.1191/1352458504MS978SR

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44754581&oldid=1621434944"